SCHEMBL760576

SCHEMBL760576

CC(C)(C)NN=C=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6649387 0.71
SCHEMBL12848613 0.69
SCHEMBL7975737 0.63
SCHEMBL9483612 0.62
SCHEMBL18754881 0.62
SCHEMBL3104317 0.58 TSHR (0.31)
SCHEMBL4908627 0.56
SCHEMBL11866635 0.56
SCHEMBL24105 0.56
SCHEMBL12764199 0.56

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109776464-A The preparation method of furan tebufenozide, intermediate and preparation method thereof 江苏省农药研究所股份有限公司 2019-05-21 CN claimed
CN-119836420-A 2-Indolone compounds as VEGFR and PKa dual-target inhibitors, preparation method and application thereof 远森制药(杭州)有限公司 2025-04-15 CN disclosed
CN-109776464-A The preparation method of furan tebufenozide, intermediate and preparation method thereof 江苏省农药研究所股份有限公司 2019-05-21 CN disclosed
US-8399473-B2 Macrocyclic spiropiperidine beta-secretase inhibitors for the treatment of Alzheimer's disease Merck, Sharp & Dohme, Corp. (US) 2013-03-19 US disclosed
EP-2073635-B1 MACROCYCLIC SPIROPIPERIDINE BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE MERCK SHARP & DOHME (US) 2012-03-21 EP disclosed
US-20100029701-A1 MACROCYCLIC SPIROPIPERIDINE BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE MERCK SHARP & DOHME LLC 2010-02-04 US disclosed